Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affimed, Artiva, Astrazeneca, Bioarctic, Eisai, Genentech, Iliad, Merus, Mesoblast, Mind Medicine, Neuraxpharm, Nobias , Phanes, Roche.